The Efficacy of Five Anthelmintic Regimes Against Trichuris Trichiura Infections in Schoolchildren in Jimma, Ethiopia

Sponsor
University Ghent (Other)
Overall Status
Completed
CT.gov ID
NCT01327469
Collaborator
VLIR-UOS Institutional University Cooperation (Other)
2,250
1
5
3
760.9

Study Details

Study Description

Brief Summary

The major soil-transmitted helminths (STHs), Ascaris lumbricoides (roundworm), Trichuris trichiura (whipworm) and Necator americanus/Ancylostoma duodenal (hookworms) are amongst the most prevalent parasites worldwide. An estimated 4.5 billion individuals are at risk for STH and more than one billion individuals are thought to be infected, of which 450 million have significant morbidity attributable from their infection, school-aged children in particular. In this population infections cause stunting of the linear growth, anemia, reduce the cognitive function and contribute to the existing malnutrition. In Jimma (Ethiopia), STH are highly prevalent, affecting more than 60% of the children (data not published).

Current efforts to control STH infections involve periodic mass drug anthelmintic treatment of infected children in endemic areas and are likely to intensify as more attention is addressed to the importance of these neglected diseases. Monitoring drug efficacy in these control programs has become indispensable in order to detect the emergence of resistance and/or identify confounding factors affecting the drug efficacy. Recently a study has evaluated a single dose albendazole (ALB) in school age children across 7 countries, including Ethiopia, revealing that this regime is highly efficacious for the treatment of A. lumbricoides (99.5%) and hookworms (94.8%), but not for T. trichiura (50.8%). For this parasite a repeated dose regime of ALB on consecutive days is likely to be more appropriate. Alternative drugs are mebendazole (single dose 500mg) and pyrantel+oxantel (single dose 10mg/kg), of which the latter holds promise as it can also be administrated to children between 6 months and 2 years. The main objective of the present study, therefore, is to assess the efficacy of 5 different treatment regimes against T. trichiura in schoolchildren in Jimma, Ethiopia, including albendazole (1 x 400mg, 2 x 400mg), mebendazole (1 x 500mg, 2x 500mg) and pyrantel-oxantel (10mg/kg)+mebendazole (500mg).

Condition or Disease Intervention/Treatment Phase
  • Drug: Albendazole, 2 x 400mg
  • Drug: Albendazole 400mg
  • Drug: Mebendazole 500mg
  • Drug: Mebendazole 2 x 500mg
  • Drug: Pyrantel-oxantel + mebendazole
Phase 4

Study Design

Study Type:
Interventional
Actual Enrollment :
2250 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
The Efficacy of 5 Anthelmintic Regimes Against T. Trichiura Infections in Schoolchildren in Jimma, Ethiopia
Study Start Date :
Dec 1, 2010
Actual Primary Completion Date :
Feb 1, 2011
Actual Study Completion Date :
Mar 1, 2011

Arms and Interventions

Arm Intervention/Treatment
Experimental: Albendazole 400mg

albendazole, 1 x 400mg

Drug: Albendazole 400mg
Albendazole 400mg

Experimental: Albendazole 2 x 400mg

albendazole, 2 x 400mg

Drug: Albendazole, 2 x 400mg
Albendazole 2 x 400mg

Experimental: Mebendazole 500mg

mebendazole, 1 x 500mg

Drug: Mebendazole 500mg
Mebendazole 500mg

Experimental: Mebendazole 2 x 500mg

mebendazole, 2x 500mg

Drug: Mebendazole 2 x 500mg
Mebendazole 2 x 500mg

Experimental: Pyrantel-oxantel + mebendazole

pyrantel-oxantel (10mg/kg)+ mebendazole (500mg)

Drug: Pyrantel-oxantel + mebendazole
Pyrantel-oxantel + mebendazole

Outcome Measures

Primary Outcome Measures

  1. Efficacy against T. trichiura of various treatment regimes [After two weeks treatment]

    The evaluation of the efficacy against T. trichiura of various treatment regimes. To this end, subjects infected with T. trichura (based on McMaster), will be randomly assigned to one of the five proposed treatment regimes. Two weeks after the treatment, faecal egg counts will be performed and the reduction in faecal egg counts will be evaluated

Eligibility Criteria

Criteria

Ages Eligible for Study:
4 Years to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • all school age children who are eligible to participate in the study
Exclusion Criteria:
  • Not willing to participate (no informed consent)

  • Unable to give samples for follow up

  • Severe intercurrent medical condition

  • Diarrhea at first sampling

  • Study subjects who had treatment for STH in the last 3 months

Contacts and Locations

Locations

Site City State Country Postal Code
1 Jimma University Jimma Ethiopia

Sponsors and Collaborators

  • University Ghent
  • VLIR-UOS Institutional University Cooperation

Investigators

  • Principal Investigator: Jozef Vercruysse, PhD, University Ghent

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT01327469
Other Study ID Numbers:
  • 2010/517
First Posted:
Apr 1, 2011
Last Update Posted:
Apr 1, 2011
Last Verified:
Mar 1, 2011

Study Results

No Results Posted as of Apr 1, 2011